Business Overview
REMSleep Holdings, Inc. develops and distributes products to help people affected by sleep apnea, primarily Deltawave CPAP machines sold through inventory channels. The company transitioned in June 2026 from a retail cash-and-carry model in Georgia to an e-commerce and e-retail focused business model based in Florida, including closure of its former Georgia office and establishment of a new warehouse facility. The company faced significant leadership change with the passing of founder and CEO Thomas Wood in February 2026, followed by board reconstitution and appointment of new management.
Segment Performance
The company reported no revenue for the three months ended March 31, 2026 or 2025, indicating no product sales during these periods. Operating expenses increased significantly to $231,348 in Q1 2026 from $131,315 in Q1 2025, driven primarily by general and administrative expenses of $180,132 (vs. $54,424 in prior year). Related party compensation expense increased to $44,140 from $27,000. Net loss widened to $289,924 in Q1 2026 compared to $85,488 in Q1 2025. Inventory increased to $70,356 from $46,304 year-over-year, representing Deltawave CPAP machines held for sale.
Key Risk Factors
The company faces substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $18.6 million, net losses of $289,924 in Q1 2026, and negative operating cash flows of $176,561. Liquidity is severely constrained with only $87,953 in cash at March 31, 2026 against current liabilities of $342,275, creating immediate solvency concerns. The company depends on uncertain future capital raises through equity issuances or debt financing to fund operations and transition to profitability. Additionally, the business faces operational risks from recent leadership transition following the CEO's death and relocation of operations.
